European Organisation For Research & Treatment Of Cancer
Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer
- Conditions
- Platinum-Sensitive Biliary Tract Cancer
- Interventions
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
- Conditions
- Limited Stage Small Cell Lung CancerExtensive-stage Small-cell Lung Cancer
- Interventions
- Radiation: Prophylactic cranial irradiation
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2023-11-03
- Target Recruit Count
- 600
- Registration Number
- NCT04790253
- Locations
- 🇦🇹
Medical University of Graz - Radio-oncology, Graz, Austria
🇧🇪Institut Jules Bordet, Anderlecht, Belgium
🇧🇪Universitair Ziekenhuis Antwerpen, Edegem, Belgium
A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma
- Conditions
- Advanced Soft-tissue Sarcoma
- Interventions
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2024-02-22
- Target Recruit Count
- 14
- Registration Number
- NCT04780464
- Locations
- 🇨🇾
Bank Of Cyprus Oncology Centre, Nicosia, Cyprus
🇯🇴King Hussein Cancer Center, Amman, Jordan
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Conditions
- Gynecologic CancerHead and Neck CancerRenal CancerBladder CancerPancreatic CancerSkin CancerSarcomaColon CancerOligometastasisEsophageal Cancer
- Interventions
- Radiation: Palliative RTRadiation: Stereotactic body radiotherapy
- First Posted Date
- 2020-08-04
- Last Posted Date
- 2024-08-26
- Target Recruit Count
- 200
- Registration Number
- NCT04498767
- Locations
- 🇧🇪
Institut Jules Bordet, Anderlecht, Belgium
🇧🇪Universitair Ziekenhuis Gent, Gent, Belgium
🇧🇪Gasthuiszusters Antwerpen - Sint-Augustinus, Wilrijk, Belgium
Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
- Conditions
- Medulloblastoma
- Interventions
- First Posted Date
- 2020-05-26
- Last Posted Date
- 2024-08-26
- Target Recruit Count
- 20
- Registration Number
- NCT04402073
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, Australia
🇦🇺Princess Alexandra Hospital - University Of Queensland, Brisbane, Australia
🇦🇺Austin Health - Austin hospital, Melbourne, Australia
REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)
- Conditions
- Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
- Interventions
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2023-11-09
- Target Recruit Count
- 2
- Registration Number
- NCT04218825
- Locations
- 🇫🇷
CHU de Bordeaux - Groupe Hospitalier Saint-Andre - Hopital Saint-Andre, Bordeaux, France
🇫🇷Assistance Publique Hopitaux Paris- APHP - APHP Nord - Univ De Paris Cite - Hop. Saint Louis, Paris, France
Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
- Conditions
- Stage IB-IIB Cutaneous T-Cell Lymphoma
- Interventions
- Radiation: Total Skin Electron Beam Therapy (TSEB)
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2024-04-05
- Target Recruit Count
- 43
- Registration Number
- NCT04128072
- Locations
- 🇩🇰
University Hospitals Copenhagen - Rigshospitalet, Copenhagen, Denmark
🇫🇷CHU de Bordeaux - Groupe Hospitalier Saint-Andre - Hopital Saint-Andre, Bordeaux, France
🇫🇷Assistance Publique Hopitaux Paris- APHP Nord - Univ De Paris Cite - Hop. Saint Louis, Paris, France
Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients
- First Posted Date
- 2019-10-15
- Last Posted Date
- 2024-11-05
- Target Recruit Count
- 68
- Registration Number
- NCT04127110
- Locations
- 🇧🇪
Institut Jules Bordet-Hopital Universitaire ULB, Brussels, Belgium
🇧🇪Cliniques Universitaires Saint-Luc, Brussels, Belgium
🇧🇪Universitair Ziekenhuis Antwerpen, Edegem, Belgium
Long-term Surival of GIST Patients ≥ 10 Years on Imatinib
- Conditions
- GIST
- Interventions
- Other: No intervention
Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome
- Conditions
- Small Intestinal NETCarcinoid Heart Disease
- Interventions